MAIA Biotechnology, Inc.
AMEX:MAIABiotechnology
+$0.05 today
- Market cap
- $80.28M
- Beta
- 0.24
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$0.76
Volume 2.25M
Average 0.78M
MAIA Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
MAIA Biotechnology, Inc.AMEX: MAIA
Total Equity · Q1 FY2026 · quarter ended Mar 2026
Total equity rises 461.7% from a year ago
Total equity stood at $27.76M at the end of Q1 FY2026, up 461.7% from a year earlier and up 1068.5% from the prior quarter. Over 3 fiscal years it compounded at -34.6% a year.
Context
- Total equity amounted to 78.6% of total assets at the end of Q1 FY2026, up 36.9 pp from a year earlier.
- Total equity increased in 1 of the last 3 fiscal years.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +461.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 2.38M USD
- Year-over-year change
- -34.6%
- 4-year CAGR
- -28.7%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.38M | -34.6% |
| FY2024 | 2024-12-31 | 3.63M | +661.2% |
| FY2023 | 2023-12-31 | 477.51K | -94.4% |
| FY2022 | 2022-12-31 | 8.51M | -7.3% |
| FY2021 | 2021-12-31 | 9.18M | — |
Total Equity vs competitors
How MAIA compares with its peers on the latest reported figures
- MAIA's Mar 2026 total equity of $27.76M is the 2nd highest of the 7 companies compared; the peer median is $6.11M.
- Its year-over-year change of +461.7% is the 2nd highest of 7, against a peer median of -46.9%.
- Total equity amounts to 78.6% of total assets for MAIA, versus a peer median of 46.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $34.79M | +65.3% | -39.5% | 80.7% | |
| Mar 2026 | $27.76M | +461.7% | -34.6% | 78.6% | |
| Mar 2026 | $11.27M | -14.4% | -4.2% | 80.7% | |
| Mar 2026 | $8.78M | +10109.3% | +23.5% | 45.8% | |
| Mar 2026 | $3.45M | -79.5% | +388.5% | 47.7% | |
| Mar 2026 | $3.13M | -87.0% | -15.9% | 19.2% | |
| Dec 2025 | -$38.06M | -530.7% | — | 35.5% | |
| Peer median (excluding MAIA) | $6.11M | -46.9% | -4.2% | 46.8% | |
Competitors are the stored peer set for MAIA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 10.57M | 10.95M | 7.15M | 9.6M | 8.66B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 43.67K | 302.79K | 144.68K | 77.35K | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | (43.67K) | 554.32K | 268.68K | 473.83K | (8.65B) |
| Total Current Assets | 10.67M | 11.81M | 7.56M | 10.15M | 9.7M |
| Property, Plant & Equipment (Net) | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 654.7K | 214K | 2.8K | 2.8K | 2.8K |
| Total Non-current Assets | 654.7K | 214K | 2.8K | 2.8K | 2.8K |
| Total Assets | 11.33M | 12.02M | 7.57M | 10.16M | 9.7M |
| Account Payables | 960.4K | 1.17M | 1.64M | 1.51M | 2.04M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 496.02K | 1.09M | 1.61M | 941.1K | 1.2M |
| Total Current Liabilities | 2.15M | 3.27M | 4.94M | 3.83M | 5.84M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 245.34K | 2.15M | 2.69M | 1.49M |
| Total Non-current Liabilities | 0 | 245.34K | 2.15M | 2.69M | 1.49M |
| Total Liabilities | 2.15M | 3.51M | 7.09M | 6.52M | 7.33M |
| Common Stock | 758 | 1.1K | 1.7K | 2.62K | 3.86K |
| Retained Earnings | (28.44M) | (44.21M) | (63.98M) | (87.23M) | (109.63M) |
| Accumulated OCI | 0 | (15.97K) | (16.26K) | (30.62K) | (50.23K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 9.18M | 8.51M | 477.51K | 3.63M | 2.38M |
| Total Debt | 0 | 0 | 0 | 0 | 0 |
| Net Debt | (10.57M) | (10.95M) | (7.15M) | (9.6M) | (8.66B) |
MAIA Biotechnology, Inc.
AMEX:MAIA
Intrinsic Alpha fair value
Locked
Current Price
$1.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.